Stocks and Investing
Stocks and Investing
Fri, September 4, 2015
[ 12:00 AM ] - WOPRAI
Thu, September 3, 2015
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, September 2, 2015
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, September 1, 2015
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, August 31, 2015
Paul Matteis Maintained (ALNY) at Buy with Increased Target to $151 on, Aug 31st, 2015
Paul Matteis of Leerink Swann, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $145 to $151 on, Aug 31st, 2015.
Paul has made no other calls on ALNY in the last 4 months.
There are 3 other peers that have a rating on ALNY. Out of the 3 peers that are also analyzing ALNY, 1 agrees with Paul's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Anupam Rama of "JP Morgan" Maintained at Hold with Decreased Target to $115 on, Friday, August 7th, 2015
These are the ratings of the 2 analyists that currently disagree with Paul
- Rahul Jasuja of "FBR Capital" Initiated at Buy and Held Target at $180 on, Tuesday, August 11th, 2015
- Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $180 on, Monday, June 15th, 2015